COMT rs4680 variant and cardiometabolic side-effects in children treated with second-generation antipsychotics

被引：0
|
作者：
Cote, Anita T. [1 ]
Panagiotopoulos, Constadina [1 ]
Devlin, Angela M. [1 ]
机构：
[1] Univ British Columbia, Vancouver, BC V5Z 1M9, Canada
来源：
FASEB JOURNAL | 2013年 / 27卷
关键词：
D O I：
暂无
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
955.1
引用
收藏
页数：1
相关论文
共 50 条
  • [1] FTO rs9939609 VARIANT DOES NOT PREDICT CARDIOMETABOLIC SIDE-EFFECTS IN CHILDREN TREATED WITH SECOND-GENERATION ANTIPSYCHOTICS
    Cote, A. T.
    Panagiotopoulos, C.
    Devlin, A. M.
    [J]. CANADIAN JOURNAL OF CARDIOLOGY, 2012, 28 (05) : S93 - S93
  • [2] Diet and cardiometabolic side effects in children treated with second-generation antipsychotics
    Barker, Mikaela K.
    Sable, Carly M.
    Montgomery, Sarah E.
    Chow, Lorrie
    Green, Timothy J.
    Panagiotopoulos, Constadina
    Devlin, Angela M.
    [J]. CLINICAL NUTRITION ESPEN, 2018, 23 : 205 - 211
  • [3] Metabolic side effects in children and adolescents treated with second-generation antipsychotics
    Alvarez-Segura, M.
    Fraguas, D.
    Merchan, J.
    Leiva, M.
    Barajas, A.
    Arango, C.
    [J]. EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2008, 18 : S563 - S563
  • [4] Metabolic and hormonal side effects in children and adolescents treated with second-generation antipsychotics
    Fraguas, David
    Merchan-Naranjo, Jessica
    Laita, Paula
    Parellada, Mara
    Moreno, Dolores
    Ruiz-Sancho, Ana
    Cifuentes, Alicia
    Giraldez, Marisa
    Arango, Celso
    [J]. JOURNAL OF CLINICAL PSYCHIATRY, 2008, 69 (07) : 1166 - 1175
  • [5] Cardiometabolic risk and the MTHFR C677T variant in children treated with second-generation antipsychotics
    A M Devlin
    Y F Ngai
    R Ronsley
    C Panagiotopoulos
    [J]. Translational Psychiatry, 2012, 2 : e71 - e71
  • [6] Cardiometabolic risk and the MTHFR C677T variant in children treated with second-generation antipsychotics
    Devlin, A. M.
    Ngai, Y. F.
    Ronsley, R.
    Panagiotopoulos, C.
    [J]. TRANSLATIONAL PSYCHIATRY, 2012, 2 : e71 - e71
  • [7] Metabolic side effects and pharmacogenetics of second-generation antipsychotics in children
    Devlin, Angela M.
    Panagiotopoulos, Constadina
    [J]. PHARMACOGENOMICS, 2015, 16 (09) : 981 - 996
  • [8] Understanding and managing cardiac side-effects of second-generation antipsychotics in the treatment of schizophrenia
    Sweeney, Mark
    Whiskey, Eromona
    Patel, Rishi K.
    Tracy, Derek K.
    Shergill, Sukhi S.
    Plymen, Carla M.
    [J]. BJPSYCH ADVANCES, 2020, 26 (01) : 26 - 40
  • [9] Extrapyramidal side-effects and antipsychotics: are second-generation agents still indicated? reply
    Peluso, Michael J.
    Lewis, Shon W.
    Barnes, Thomas R. E.
    Jones, Peter B.
    [J]. BRITISH JOURNAL OF PSYCHIATRY, 2012, 201 (03) : 247 - 248
  • [10] Second-generation antipsychotics and metabolic side-effects: Canadian population-based study
    Hirsch, Lauren
    Patten, Scott B.
    Bresee, Lauren
    Jette, Nathalie
    Pringsheim, Tamara
    [J]. BJPSYCH OPEN, 2018, 4 (04): : 256 - 261
12345